- Home
- ADBE vs GSK Comparison
ADBE vs GSK Comparison
Compare ADBE & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADBE | GSK |
|---|---|---|
| Founded | 1982 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | 66841 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.2B | 116.3B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | ADBE | GSK |
|---|---|---|
| Price | $245.39 | $57.87 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 29 | 2 |
| Target Price | ★ $352.63 | N/A |
| AVG Volume (30 Days) | ★ 4.5M | 3.9M |
| Earning Date | 03-12-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.95% |
| EPS Growth | ★ 35.11 | N/A |
| EPS | ★ 4.60 | N/A |
| Revenue | ★ $23,769,000,000.00 | N/A |
| Revenue This Year | $11.79 | $6.70 |
| Revenue Next Year | $8.80 | $4.22 |
| P/E Ratio | $51.24 | ★ $32.75 |
| Revenue Growth | ★ 10.53 | N/A |
| 52 Week Low | $224.13 | $35.08 |
| 52 Week High | $422.95 | $61.70 |
Technical Indicators
Market Signals| Indicator | ADBE | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 49.12 | 59.04 |
| Support Level | $233.16 | $47.89 |
| Resistance Level | $247.44 | $60.37 |
| Average True Range (ATR) | 8.00 | 1.04 |
| MACD | 1.24 | 0.45 |
| Stochastic Oscillator | 90.27 | 70.76 |
Price Performance
Historical ComparisonAbout ADBE Adobe Inc.
Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing, and engaging with compelling content multiple operating systems, devices, and media. The company operates with three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.